David Lyerly

Co-Founder at TechLab, Inc.

David Lyerly

David Lyerly

Co-Founder at TechLab, Inc.

Overview
Career Highlights

TechLab, Inc.

RelSci Relationships

19

Number of Boards

2

Relationships
RelSci Relationships are individuals David Lyerly likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at TechLab, Inc.

Relationship likelihood: Strong

Partner at Pharos Capital Group LLC

Relationship likelihood: Strong

Founding Partner & Chief Investment Officer at Pharos Capital Group LLC

Relationship likelihood: Strong

Founding Partner & Chairman at Pharos Capital Group LLC

Relationship likelihood: Strong

Executive Officer at Motion PT Holdings, Inc.

Relationship likelihood: Strong

Co-Founder at TechLab, Inc.

Relationship likelihood: Strong

Co-Chief Financial Officer at Pharos Capital Group LLC

Relationship likelihood: Strong

Chief Financial Officer & Chief Compliance Officer at Pharos Capital Group LLC

Relationship likelihood: Strong

Partner at Pharos Capital Group LLC

Relationship likelihood: Strong

Partner at Pharos Capital Group LLC

Relationship likelihood: Strong

Paths to David Lyerly
Potential Connections via
Relationship Science
You
David Lyerly
Co-Founder at TechLab, Inc.
Career History
Co-Founder
2016 - Current

TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA.

Boards & Committees
Director & Chief Scientific Officer
2016 - Current

TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA.

Board Member
2016 - Current

Pharos Capital Group invests primarily in established businesses based in the US with EBITDA of at least $2 million, revenue of at least $10 million. The firm seeks to provide growth stage capital for businesses and invests across sectors with a focus on healthcare, business services, drug development, life sciences, biotechnology and technology sectors. They provide funding for acquisitions, leveraged buyouts, management buyouts, and recapitalizations with an investment size ranging from $20 million to $50 million.Pharos Capital prefers to invest in companies that offer multiple exit opportunities which may include a financial buyer, an IPO, a recapitalization or a sale to a strategic purchaser.

Investments
Details Hidden

TechLab, Inc. develops, manufactures, and distributes rapid non-invasive intestinal diagnostics. It focuses on enteric disease and microbiology of the intestinal tract, and scope of study includes markers of intestinal inflammation, the toxins of Clostridium difficile, amebiasis, and vaccine development. It offers diagnostic tests for colitis, parasitology, intestinal inflammation, and Shiga toxins of enterohemorrhagic E. coli. The company was founded by Tracy Wilkins in 1989 and is headquartered in Blacksburg, VA.

Other Affiliations

David Lyerly is affiliated with TechLab, Inc., TechLab, Inc., Pharos Capital Group LLC

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David Lyerly. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David Lyerly's profile does not indicate a business or promotional relationship of any kind between RelSci and David Lyerly.